More Than 200 Companies Advance Trial Management with 吃瓜爆料 CTMS

Biopharmas use leading CTMS for improved trial efficiency and collaboration

PLEASANTON, CA — Jan. 29, 2025 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use 吃瓜爆料 CTMS to execute faster, more efficient trials. As study complexity and data volumes increase, biopharmas and CROs are centralizing data and documents with 吃瓜爆料 CTMS to streamline processes and drive stakeholder collaboration.

“吃瓜爆料 CTMS is the central hub of our trials, allowing study metrics and documents to flow seamlessly across our ecosystem,” said Bonne Adams, vice president of operations at Inhibrx. “Using clinical applications on a connected platform saves time and effort for our lean team and improves how we work with CRO partners.”

Whether biopharmas insource or outsource trials, clinical teams can use 吃瓜爆料 CTMS to proactively manage studies and quickly identify and address issues. With a flexible and scalable system, companies can accelerate trial execution and deliver high-quality data while maintaining compliance with global regulations like ICH E6(R2) and (R3).

To help biopharmas adapt to trial operating model changes and keep up with evolving regulations, 吃瓜爆料 continues to deliver clinical innovations. New 吃瓜爆料 CTMS advancements include:

CTMS transfer automates daily data transfers from CROs to sponsors for greater visibility
Oversight issue tracking and management for faster resolution
Enhancements to manage insourced, outsourced, and complex trials for speed and agility

“Modern clinical trial management systems should scale easily and support both insourced and outsourced operating models,” said Henry Galio, vice president of 吃瓜爆料 CTMS strategy. “To provide this flexibility, we’re delivering new capabilities for 吃瓜爆料 CTMS through our three product releases per year, continuously advancing to help the industry work better together and accelerate execution.”

With the increased adoption of 吃瓜爆料 CTMS, more companies are simplifying trial operations and maintaining compliance regardless of operating model. 吃瓜爆料 CTMS is part of 吃瓜爆料 Clinical Platform, the most complete and highest-quality platform for faster and more efficient trials. Learn more about 吃瓜爆料 CTMS at booth 916, Feb. 3-6 in Orlando.

Additional Information
For more on 吃瓜爆料 CTMS, visit: veeva.com/CTMS
Connect with 吃瓜爆料 on LinkedIn:

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit .

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find??(a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at?.

###

Contact:

Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com